Clinical Trial Update: Interleukin-1 Blockade in HF With Preserved EF [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating interleukin-1 blockade in heart failure with preserved ejection fraction has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Heart Failure With Normal Ejection Fraction | Phase 2 | Status: COMPLETED | Results posted: 2018-06-19